Table 1 Comparisons of clinical features and laboratory findings between the normal thyroid group and the thyroid dysfunction group.
From: The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study
 | Normal thyroid (n = 57) | Thyroid dysfunction (n = 260) | P |
---|---|---|---|
Clinical characteristics | |||
Age (Year) | 41.3 ± 14.33 | 40.65 ± 16.16 | 0.779 |
Male (%) | 31(54.40%) | 139(53.60%) | 0.517 |
Duration of NS (Month) | 3.00 [1.00, 8.00] | 6.00 [1.00, 10.00] | 0.098 |
HB (g/L) | 143.14 ± 23.55 | 132.24 ± 25.17 | 0.003 |
WBC (109/L) | 7.36 ± 2.53 | 8.02 ± 3.41 | 0.099 |
PLT (109/L) | 202.23 ± 72.02 | 232.79 ± 86.77 | 0.014 |
UA (umol/L) | 354.36 ± 87.87 | 361.52 ± 102.29 | 0.637 |
PRO (g/24 h) | 4.03 ± 2.45 | 8.27 ± 6.56 | <0.001 |
PCR (g/mmol Cr) | 0.47 ± 0.4 | 0.9 ± 0.6 | <0.001 |
ALB (g/L) | 28.68 ± 6.19 | 22.08 ± 5.88 | <0.001 |
SCR (umol/L) | 55.00 [61.00, 75.5] | 70.00 [55.00, 104.95] | 0.027 |
TG (mmol/L) | 2.03 ± 1.06 | 2.46 ± 1.6 | 0.055 |
TC (mmol/L) | 7.15 ± 2.24 | 8.48 ± 3.23 | <0.001 |
LDL (mmol/L) | 4.54 ± 1.93 | 5.54 ± 2.78 | 0.002 |
FT3 (pmol/L) | 4.49 ± 0.64 | 3.17 ± 1.39 | <0.001 |
TT3 (nmol/L) | 1.64 ± 0.26 | 1.2 ± 0.43 | <0.001 |
FT4 (pmol/L) | 15.8 ± 2.18 | 12.81 ± 3.42 | <0.001 |
TT4 (nmol/L) | 87.32 ± 12.8 | 66.07 ± 25.38 | <0.001 |
TSH (mU/L) | 4.57 [2.60, 6.81] | 3.00 [2.02, 3.60] | <0.001 |
RT3 (nmol/L) | 0.36 ± 0.14 | 0.3 ± 0.15 | 0.215 |
Coexisting diseases (%) | |||
Hypertension | 17.50% | 20.20% | 0.653 |
Diabetes | 1.80% | 5.70% | 0.365 |
Pulmonary infection | 7.00% | 15.20% | 0.157 |
AKI | 1.80% | 4.20% | 0.624 |
CKD | 1.80% | 8.00% | 0.163 |
Renal biopsy (%) | |||
MN | 40.4% | 30.7% | 0.339 |
MCD | 28.1% | 36.2% | Â |
IgAN | 10.5% | 7.8% | Â |
MPGN | 3.5% | 1.9% | Â |
MsPGN | 0.00% | 3.50% | Â |
FSGS | 3.5% | 3.5% | Â |
Secondary NS | 14.0% | 16.3% | Â |